Chiemi Hayakawa
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders 8
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism 5
-
- Genetics and Neurodevelopmental Disorders 4
- Genomic variations and chromosomal abnormalities 2
-
- Neonatal and fetal brain pathology 1
-
- Peroxisome Proliferator-Activated Receptors 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- Epilepsy research and treatment 2
- Co-authors
- Naoki MizutaniToshiyuki KumagaiYukihiro OhyaTsutomu YamanakaNobuaki WakamatsuShuji MiyazakiYasukazu YamadaKazuyoshi Watanabe
- Journals
- The American Journal of Human Genetics (1 paper)Epilepsia (1 paper)Human Mutation (2 papers)
- Partner nations
- JapanNetherlandsUnited Kingdom
In The Last Decade
Chiemi Hayakawa
20 papers receiving 334 citations
Peers
Comparison fields: 5 of 60
- Clinical Biochemistry 94
- Biochemistry 45
- Genetics 119
- Developmental Neuroscience 11
- Pediatrics, Perinatology and Child Health 52
Countries citing papers authored by Chiemi Hayakawa
This map shows the geographic impact of Chiemi Hayakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiemi Hayakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiemi Hayakawa more than expected).
Fields of papers citing papers by Chiemi Hayakawa
This network shows the impact of papers produced by Chiemi Hayakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiemi Hayakawa. The network helps show where Chiemi Hayakawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chiemi Hayakawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2021 | 6 | |
| 3 | 2007 | 9 | |
| 4 | 2006 | 23 | |
| 5 | [Tracheostomy for home-care patients with severe motor and intellectual disabilities]. | 2005 | 2 |
| 6 | [Clinical symptoms of the Rett syndrome patients with MECP2 gene abnormalities]. | 2005 | 2 |
| 7 | 2002 | 12 | |
| 8 | 2001 | 6 | |
| 9 | 2001 | 19 | |
| 10 | 2001 | 76 | |
| 11 | 1999 | 8 | |
| 12 | 1992 | 70 | |
| 13 | 1991 | 41 | |
| 14 | 1991 | 2 | |
| 15 | 1987 | 3 | |
| 16 | 1987 | 12 | |
| 17 | 1987 | 35 | |
| 18 | [The development of a radioimmunoassay for somatostatin]. | 1987 | 1 |
| 19 | 1987 | 8 | |
| 20 | 1983 | 14 |
About Chiemi Hayakawa
Chiemi Hayakawa is a scholar working on Clinical Biochemistry, Biochemistry and Developmental Neuroscience, having authored 20 papers that have together received 350 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (8 papers), Amino Acid Enzymes and Metabolism (5 papers), Genetics and Neurodevelopmental Disorders (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Epilepsy research and treatment (2 papers) and Neonatal and fetal brain pathology (1 paper). The work is most often cited by research in Clinical Biochemistry (94 citations), Biochemistry (45 citations) and Genetics (119 citations). Chiemi Hayakawa has collaborated with scholars based in Japan, Netherlands and United Kingdom. Frequent co-authors include Naoki Mizutani, Toshiyuki Kumagai, Yukihiro Ohya, Tsutomu Yamanaka, Nobuaki Wakamatsu, Shuji Miyazaki, Yasukazu Yamada, Kazuyoshi Watanabe, Akiko Matsumoto and Nobuhiko Ochi. Their work appears in journals such as The American Journal of Human Genetics, Epilepsia and Human Mutation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.